Hormone Therapy Heart Disease Risk Negligible For Women Near Menopause
Executive Summary
A secondary analysis of the Women's Health Initiative randomized controlled trials of hormone therapy could have favorable implications for Wyeth's menopause franchise
You may also be interested in...
Wyeth Using Unbranded Ads To Stimulate Premarin, Prempro Growth
Wyeth's latest direct-to-consumer advertising campaign for its estrogen franchise suggests emerging use of unbranded ads for leading products in mature markets
NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination
Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue
FDA’s Arcoxia Decision Offers New Evidence Of Conservative Review Stance
FDA's "not approvable" action on Merck's Vioxx follow-on Arcoxia for the treatment of symptoms of osteoarthritis could be indicative of a conservative regulatory climate at the agency